Literature DB >> 12195006

A tumour with a neuroendocrine and papillary serous component: two or a pair?

S Van Eeden1, P M Nederlof, B G Taal, G J A Offerhaus, M-L F Van Velthuysen.   

Abstract

AIMS: To examine the clonal origin of a tumour, made up of a neuroendocrine component and a papillary serous component by comparing the pattern of loss of heterozygosity (LOH) and the immunohistochemical protein expression of both components. METHODS/
RESULTS: A 70 year old woman, known to have a metastasised neuroendocrine carcinoma, underwent resection of the distal part of the ileum because of obstruction by a mesenterial mass. The macroscopically homogeneous mesenterial mass consisted histologically of an admixture of a neuroendocrine component and a papillary serous carcinoma. Loss of heterozygosity (LOH) analysis of both components with a panel of 15 polymorphic microsatellite markers showed a distinctive pattern of LOH, and both components showed LOH on chromosome 4q and 17, but involving different alleles at the same locus. Moreover, both components showed different immunohistochemical staining patterns for neuroendocrine markers, cytokeratin 7, carcinoembryonic antigen, and CA125.
CONCLUSION: Both LOH analysis of the neuroendocrine and papillary serous components of this tumour and the immunohistochemical profile of both components are consistent with a different clonal origin. The tumour is probably a collision tumour, in which the papillary serous carcinoma must have been of peritoneal origin because necropsy revealed a normal uterus and normal ovaries.

Entities:  

Mesh:

Year:  2002        PMID: 12195006      PMCID: PMC1769742          DOI: 10.1136/jcp.55.9.710

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.

Authors:  A Hartmann; U Rösner; G Schlake; W Dietmaier; D Zaak; F Hofstaedter; R Knuechel
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

2.  Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.

Authors:  B G Taal; C A Hoefnagel; R A Valdes Olmos; H Boot; J H Beijnen
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

3.  Molecular evidence of field cancerization in a patient with 7 tumors of the aerodigestive tract.

Authors:  B P van Rees; A M Cleton-Jansen; H A Cense; M M Polak; M J Clement; P Drillenburg; J J van Lanschot; G J Offerhaus
Journal:  Hum Pathol       Date:  2000-02       Impact factor: 3.466

4.  Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study.

Authors:  J Zhou; Y Iwasa; I Konishi; N Kan; R Kannagi; Y Kobashi; Y C Kim; H Yamabe
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

5.  Mechanisms underlying losses of heterozygosity in human colorectal cancers.

Authors:  S Thiagalingam; S Laken; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Molecular identification of metastatic cancer to the skin using laser capture microdissection: a case report.

Authors:  S Milchgrub; I I Wistuba; B K Kim; C Rutherford; J Urban; P D Cruz; A F Gazdar
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

7.  Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma.

Authors:  A Zahedi; G L Booth; H S Smyth; W E Farrell; R N Clayton; S L Asa; S Ezzat
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

8.  Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.

Authors:  B G Taal; C A Hoefnagel; R A Valdés Olmos; H Boot
Journal:  Eur J Cancer       Date:  1996-10       Impact factor: 9.162

9.  Composite carcinoma-carcinoid tumors of the gastrointestinal tract. A morphologic, histochemical, and immunocytochemical study.

Authors:  R S Klappenbach; R J Kurman; C F Sinclair; L P James
Journal:  Am J Clin Pathol       Date:  1985-08       Impact factor: 2.493

10.  Adenoma-carcinoid tumors of the colon.

Authors:  M H Lyda; C M Fenoglio-Preiser
Journal:  Arch Pathol Lab Med       Date:  1998-03       Impact factor: 5.534

View more
  3 in total

Review 1.  Collision of three histologically distinct endometrial cancers of the uterus.

Authors:  Ki-Seok Jang; Won-Moo Lee; Young-Jae Kim; Sam-Hyun Cho
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

2.  A collision tumor of esophagus.

Authors:  Bin Yao; Shanghui Guan; Xiaochen Huang; Peng Su; Qingxu Song; Yufeng Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Three histologically distinct cancers of the uterine corpus: A case report and review of the literature.

Authors:  Hisashi Masuyama; Junko Haraga; Takashi Nishida; Chikako Ogawa; Tomoyuki Kusumoto; Keiichiro Nakamura; Noriko Seki; Hiroyuki Yanai; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2016-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.